Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06546046

Analysis of the Efficacy and Stability of a Wearable ECG Monitor

Analysis of the Efficacy and Stability of a Single-Channel Patch-Type Wearable Electrocardiogram Monitor

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Mezoo Co., Ltd. · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring

Detailed description

This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring. After the data collection is completed, a satisfaction survey will be conducted with the medical staff. The data obtained simultaneously from HiCardi+ and MX40 will be analyzed, and the satisfaction survey responses from the medical staff will be reviewed to confirm the clinical convenience of the patch-type ECG monitoring device.

Conditions

Interventions

TypeNameDescription
DEVICEECG monitoring by telemetry device and patch-type ECG monitor at the same timeThe patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.

Timeline

Start date
2024-09-09
Primary completion
2024-12-30
Completion
2025-03-30
First posted
2024-08-09
Last updated
2024-08-14

Source: ClinicalTrials.gov record NCT06546046. Inclusion in this directory is not an endorsement.